Founders Capital Management Adamis Pharmaceuticals Corp Transaction History

Founders Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	SELL	$0.14 - $0.22 $1,820 - $2,860	-13,000 Reduced 72.22%	5,000 $1,000
Q2 2021 Jul 15, 2021	BUY	$0.66 - $1.23 $6,600 - $12,300	10,000 Added 125.0%	18,000 $20,000
Q4 2019 Jan 24, 2020	BUY	$0.51 - $1.26 $2,040 - $5,040	4,000 Added 100.0%	8,000 $6,000
Q3 2019 Oct 10, 2019	BUY	$0.7 - $1.46 $1,400 - $2,920	2,000 Added 100.0%	4,000 $3,000
Q3 2018 Oct 05, 2018	BUY	$2.25 - $4.8 $4,500 - $9,600	2,000 New	2,000 $7,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.